Home / Inspections / 1022524

FDA Inspection 1022524 — Medtronic Neuromodulation

Medtronic Neuromodulation — FEI 2182207

The FDA completed an inspection of Medtronic Neuromodulation on June 7, 2017 in Minneapolis, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 7, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Minneapolis, MN (United States)

Facility

Other inspections at this facility

  • 1206222 (VAI Fri May 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1187313 (VAI Thu Nov 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1153966 (NAI Thu Sep 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108789 (VAI Thu Oct 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102180 (NAI Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources